---
title: Axcelead Drug Discovery Partners, Inc. vs Explicyte
slug_a: axcelead
slug_b: explicyte
site: cro
review_signal_gate: closed
canonical_path: /compare/axcelead/explicyte
---

# Axcelead Drug Discovery Partners, Inc. vs Explicyte

Side-by-side profile data from each company listing on this directory.

## Axcelead Drug Discovery Partners, Inc.

- Profile: [/companies/axcelead](/companies/axcelead)

Axcelead Drug Discovery Partners, Inc. — Axcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities.

Services: 27. Modalities: 6. Indications: 6. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (27).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Genetic Toxicology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Specialized & Large-Animal Models
- Bioanalysis
- Biomarker Assays
- Flow Cytometry Services
- Translational Research
- Immunology & Inflammation Services
- Oncology Specialty Services
- CNS Specialty Services
- Cardiovascular & Metabolic Specialty Services
- Pathology & Histology Services
- Genomics & Sequencing Services
- Proteomics Services
- Bioinformatics & Data Science

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- mRNA
- Peptide

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Nephrology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)

## Explicyte

- Profile: [/companies/explicyte](/companies/explicyte)

Explicyte — Oncology CRO offering FFPE target discovery, 2D/3D immuno-oncology efficacy and mechanism-of-action assays, and ISO-certified IHC/IF trial biomarker services. Serves biotech and pharma sponsors.

Services: 13. Modalities: 2. Indications: 1. Locations: 1. Certifications: 3. The strongest documented coverage currently appears in services (13).

### Services

- Discovery Research
- Target Identification & Validation
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- Biomarker Assays
- Flow Cytometry Services
- Translational Research
- Immunology & Inflammation Services
- Oncology Specialty Services
- Pathology & Histology Services
- Genomics & Sequencing Services
- Proteomics Services
- Bioinformatics & Data Science

### Modalities

- Biologics (Other)
- Antibody-Drug Conjugate (ADC)

### Indications

- Oncology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Data not yet provided.